Medication-taking behavior and drug self regulation in people with epilepsy

被引:12
作者
Gomes, MD
Maia, HD
机构
[1] Univ Fed Rio de Janeiro, Univ Hosp, Fac Med, Inst Neurol,Epilepsy Program, BR-21941 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Univ Hosp, Fac Med, Dept Internal Med,Clin Epidemiol Program, BR-21941 Rio De Janeiro, Brazil
关键词
epilepsy; adherence; antiepileptic drug;
D O I
10.1590/S0004-282X1998000500003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: To study the most important characteristics of antiepileptic drug (AED) taking behavior in epileptic people, Methods: In a cross-sectional study, 45 consecutively seen patients answered a standardized questionnaire including questions about drug intake behavior. Results: Both genders were equally represented (22M x 23F). The mean age was 30.2 years. No specific characteristic were presented in all patients. The self-reported non-use of the drug at any moment one week before (self-reported non-adherence) was 40.0%. Patients took the drug more than once in most cases (75.0%), and the only precipitating factor of seizures more frequently avoided was alcohol intake (66.7%). Forty-four percent said to be afraid of becoming addicted to the medicine, 61.4% reduced or stopped the medicine just to see what would happen, and 47.7% changed the prescription with the same purpose. There is no relationship among socio-demographic, behavior aspects or treatment characteristics, and self-reported non-adherence. Conclusion: Several patient's aspects de net seem to be strongly correlated with self-reported adherence. Nevertheless, drug self-regulation is probably related to the drug-intake behavior, and it is important for the physician to understand this parallel influence an treatment for a more realistic approach.
引用
收藏
页码:714 / 719
页数:6
相关论文
共 12 条
[1]   DETERMINANTS OF COMPLIANCE IN EPILEPTIC OUTPATIENTS [J].
BRYANT, SG ;
ERESHEFSKY, L .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1981, 15 (7-8) :572-577
[2]   THE MEANING OF MEDICATIONS - ANOTHER LOOK AT COMPLIANCE [J].
CONRAD, P .
SOCIAL SCIENCE & MEDICINE, 1985, 20 (01) :29-37
[3]  
EISLER J, 1975, EPILEPSIA, V16, P203
[4]   Anti-epileptic drug intake adherence - The value of the blood drug level measurement and the clinical approach [J].
Gomes, MD ;
Maia, HD ;
Noe, RAM .
ARQUIVOS DE NEURO-PSIQUIATRIA, 1998, 56 (04) :708-713
[5]   CAN SIMPLE CLINICAL MEASUREMENTS DETECT PATIENT NON-COMPLIANCE [J].
HAYNES, RB ;
TAYLOR, DW ;
SACKETT, DL ;
GIBSON, ES ;
BERNHOLZ, CD ;
MUKHERJEE, J .
HYPERTENSION, 1980, 2 (06) :757-764
[6]  
Leppik IL, 1996, TREATMENT EPILEPSY P, P779
[7]   DETERMINANTS OF PATIENT COMPLIANCE WITH ANTI-CONVULSANT THERAPY [J].
PETERSON, GM ;
MCLEAN, S ;
MILLINGEN, KS .
EPILEPSIA, 1982, 23 (06) :607-613
[8]   IS THIS PATIENT TAKING THE TREATMENT AS PRESCRIBED [J].
STEPHENSON, BJ ;
ROWE, BH ;
HAYNES, RB ;
MACHARIA, WM ;
LEON, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (21) :2779-2781
[9]   MONITORING DRUG NONCOMPLIANCE IN EPILEPTIC PATIENTS - ASSESSING PHENOBARBITAL PLASMA-LEVELS [J].
TAKAKI, S ;
KUROKAWA, T ;
AOYAMA, T .
THERAPEUTIC DRUG MONITORING, 1985, 7 (01) :87-91
[10]  
Trostle J, 1988, Epilepsy Res Suppl, V1, P57